Explore 3 Stock Ideas & Industry Insights Download Free Report

News

RTX Corp. (NYSE:RTX): R2S JV Wins USD 1.25 Bn Tamir Missile Supply Contract

RTX Corp. (NYSE:RTX) has received a notable uplift with its Raytheon-Rafael Protection Systemsjoint venturesecuring a USD 1.25 bln contract to supply Israel with Tamir surface-to-air missiles. The comprehensive order includes missile kits and associated test equipment, underscoring continued global interest in the Tamir interceptor’s …

Team Kalkine | 24 November 2025

KB Home (NYSE:KBH): Multiple Community Launches Spark Interest

KB Home (NYSE:KBH) announced significant expansion activity across Florida and California. One of the company’s newest additions is a single-family home community in St. Cloud, Florida. This development emphasizes energy-efficient construction, access to well-regarded schools, and proximity to daily conveniences. The launch aligns with …

Team Kalkine | 24 November 2025

Pfizer (NYSE:PFE) Advances Oncology Portfolio with PADCEV + Keytruda Regimen

Pfizer Inc. (NYSE:PFE) and Astellas Pharma Inc. announced that the U.S.Food and Drug Administrationhas granted approval for PADCEV (enfortumab vedotin-ejfv) in combination with Merck’s Keytruda (pembrolizumab) or Keytruda QLEX. The therapy is now cleared for perioperative use in adults with muscle-invasive bladder cancer (MIBC) …

Team Kalkine | 24 November 2025

Gilead Sciences (NASDAQ:GILD) Finalizes Acquisition of TREX1 Program from Sprint Bioscience

Gilead Sciences (NASDAQ:GILD) has completed the acquisition of the TREX1 cancer program from Sprint Bioscience AB. The agreement includes an upfront payment of USD 14 million and future potential milestone payments that could reach as high as USD 400 million.

Team Kalkine | 24 November 2025

Sanford C. Bernstein Raises ConocoPhillips (NYSE:COP) Target; Outperform Maintained

Sanford C. Bernstein has increased its price objective for ConocoPhillips (NYSE:COP) from USD 115.00 to USD 116.00 in a recent research report. The brokerage reiterated an “outperform” rating, indicating confidence in the company’s outlook within the energy sector. ConocoPhillips operates a diversified global portfolio …

Aditi Sarkar | 23 November 2025

UBS Group Reiterates Buy Rating on NVIDIA (NASDAQ:NVDA) as Analysts Lift Targets

UBS Group has reiterated its Buy rating on NVIDIA Corporation (NASDAQ:NVDA), according to a research note shared on Thursday. The brokerage also kept its target price at USD 235, reinforcing its recent assessment of the semiconductor and computing hardware company. The latest update comes …

Team Kalkine | 21 November 2025

Equities Reverse Gains, Commodities Weaken, Dollar Strengthens, and Yields Hold Steady

Market Movers:On Thursday, the top gainers were Mobile-health Network Solutions (+83.13%), followed by Epsium Enterprise Limited. (+66.36%). On the contrary Brera Holdings PLC. (-63.73%), and mF International Limited (-39.06%) declined the most the same day.

Team Kalkine | 21 November 2025

Veeva Systems (NYSE:VEEV) Reports 16% Q3 Revenue Growth as Cloud Demand Expands

Veeva Systems (NYSE:VEEV) reported a meaningful revenue increase for its fiscal third quarter ended October 31, 2025, supported by steady demand for its cloud-based solutions tailored to the life sciences sector. Totalrevenuerose 16%year-over-yearto USD 811.2 million, compared with USD 699.2 million in Q3 FY25. …

Team Kalkine | 21 November 2025

Crinetics (NASDAQ:CRNX) Begins Pivotal Trial Evaluating Paltusotine in Carcinoid Syndrome

Crinetics Pharmaceuticals Inc. (NASDAQ:CRNX) has initiated its Phase 3 CAREFNDR clinical trial evaluating paltusotine in adults with carcinoid syndrome, marking a major step toward expanding the therapeutic reach of its flagship drug. Carcinoid syndrome affects roughly 20 percent of people with neuroendocrine tumors, most …

Team Kalkine | 21 November 2025

SynCardia Systems (NASDAQ:PMI) Reaches Milestone with First Implantations of Emperor Artificial Heart

SynCardia Systems, LLC, a subsidiary of Picard Medical Inc. (NASDAQ:PMI), has reached a defining moment in the advancement of artificial organ technology. The company confirmed the first successful in vivo implantations of its fully implantable Emperor Total Artificial Heart, marking a pivotal milestone in …

Team Kalkine | 21 November 2025